Author

Essha Chatterjee

Observed name: Chatterjee, Essha

Institutions: Sambalpur University, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research

Observed institutions: Sambalpur University, Chittaranjan National Cancer Institute, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research

OpenAlex ID: A5046736357

Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms

2021 · Paras Famta, Saurabh Shah, et al. · Current Research in Pharmacology and Drug Discovery · 62

PDF

Fucoidan-mediated targeted delivery of dasatinib-loaded nanoparticles amplifies apoptosis and endows cytotoxic potential in triple-negative breast cancer

2023 · Brojendra Nath Saren, Srushti Mahajan, et al. · Colloids and Surfaces B Biointerfaces · 42

Antiproliferative Potential of Gloriosine: A Lead for Anticancer Drug Development

2022 · Bharat Goel, Biswajit Dey, et al. · ACS Omega · 20

Oral linalool-based nanoemulsion of acalabrutinib for ameliorating its oral bioavailability and in vitro anticancer potential in T lymphoblast cell lines

2024 · Arti Shettiwar, Ujala Gupta, et al. · Colloid & Polymer Science · 13

Harnessing the targeting potential of hyaluronic acid for augmented anticancer activity and safety of duvelisib-loaded nanoparticles in hematological malignancies

2024 · Srushti Mahajan, Mayur Aalhate, et al. · International Journal of Biological Macromolecules · 11

LCMS-DNP based dereplication of Araucaria cunninghamii Mudie gum-resin: identification of new cytotoxic labdane diterpene

2022 · Bharat Sahu, Nivedita Bhardwaj, et al. · Natural Product Research · 11

Identification and Evaluation of Apoptosis-Inducing Activity of Ipomone from Ipomoea nil : A Novel, Unusual Bicyclo-[3.2.1] Octanone Containing Gibberic Acid Diterpenoid

2021 · Bharat Goel, Essha Chatterjee, et al. · ACS Omega · 11

Solid Self Nano-Emulsifying Drug Delivery System of Dasatinib: Optimization, In-vitro , Ex-vivo and In-vivo assessment

2024 · Mohd Aman Mohd Ateeq, Srushti Mahajan, et al. · Therapeutic Delivery · 10

PDF

Anticancer activity of RM-3-22: a TAZQ-based hydroxamic acid derivative targeting NSCLC in vitro and in vivo

2025 · Essha Chatterjee, Ram Sharma, et al. · Frontiers in Pharmacology · 7

PDF

RETRACTED ARTICLE: High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence

2021 · Mukta Basu, Amvrin Chatterjee, et al. · Journal of Cancer Research and Clinical Oncology · 7

Induction of apoptosis in human bladder cancer cells by triterpenoids isolated from Holarrhena antidysenterica through differential reactive oxygen species generation

2020 · Anindita Ghosh, Rituparna Roy, et al. · Natural Product Research · 5

Prioritization of the Secondary Metabolites for the Rapid Annotation Based on Liquid Chromatography-High Resolution Mass Spectrometry Assessment: Varanasine and Schroffanone from Murraya paniculata and Cytotoxic Evaluation

2024 · Sanju Kumari, Bhavana Prathyusha, et al. · Journal of Proteome Research · 3

The HDAC Inhibitor RM-3-22 Suppresses Triple-Negative Breast Cancer by Uncoupling Autophagy to Drive FSP1-Dependent Ferroptosis

2026 · Essha Chatterjee, Biswajit Dey, et al. · Translational research · 1

Autophagy-lysosomal dependency defines a vulnerable physiological state in drug-tolerant persister cells of triple-negative breast cancer

2026 · Essha Chatterjee, Biswajit Dey, et al. · APOPTOSIS · 1

Mechanistic insights into gallic acid–induced autophagy in triple negative breast cancer through network pharmacology, molecular docking, and in vitro validation

2026 · Essha Chatterjee, Biswajit Dey, et al. · Functional & Integrative Genomics

A Thieno[3,2-D] pyrimidine class of p110α/GDH1 dual inhibitor SBS-873 suppresses TNBC growth by inhibiting PI3K/mTOR signaling and inducing ferroptosis through glutathione depletion

2026 · Biswajit Dey, Essha Chatterjee, et al. · Cellular Signalling

Glutamate dehydrogenase 1 (GDH1) sustains triple-negative breast cancer persister cell survival by coordinating mitochondrial fusion and anaplerotic flux

2026 · Biswajit Dey, Essha Chatterjee, et al. · Cellular and Molecular Life Sciences

Repurposed Axitinib delivered via lipid-extruded PEGylated liposomes: 2D/3D breast cancer cell evaluation and in-vivo pharmacokinetics

2026 · Avinash Pawar, Ekta Pardhi, et al. · Figshare

Repurposed Axitinib delivered via lipid-extruded PEGylated liposomes: 2D/3D breast cancer cell evaluation and in-vivo pharmacokinetics

2026 · Avinash Pawar, Ekta Pardhi, et al. · Journal of Liposome Research

CCDC 2467753: Experimental Crystal Structure Determination

2026 · Kumari, Sanju, Prathyusha, Bhavana, et al. · The Cambridge Structural Database

CCDC 2467755: Experimental Crystal Structure Determination

2026 · Kumari, Sanju, Prathyusha, Bhavana, et al. · The Cambridge Structural Database

Unveiling Gloriosine as a Dual-Acting Regulator of Glutamine Metabolism and Ferroptosis in Triple-Negative Breast Cancer: Insights from Network Pharmacology and Experimental Validation

2026 · Biswajit Dey, Essha Chatterjee, et al. · bioRxiv (Cold Spring Harbor Laboratory)

YAP inhibition by gloriosine unlocks autophagic cell death as an anticancer strategy in lung malignancies

2026 · Biswajit Dey, Bharat Goel, et al. · European Journal of Pharmacology

Retraction Note: High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence

2026 · Mukta Basu, Amvrin Chatterjee, et al. · Journal of Cancer Research and Clinical Oncology

PDF

Corrigendum to “Harnessing the targeting potential of hyaluronic acid for augmented anticancer activity and safety of duvelisib-loaded nanoparticles in hematological malignancies” [Int. J. Biol. Macromol. 282 (2024) 136600]

2024 · Srushti Mahajan, Mayur Aalhate, et al. · International Journal of Biological Macromolecules

Works count: 29

Citation count: 204

H-index: 8

I10-index: 8